LEAH LILLMARS: Open Payments
NPI 1346514304 · NORTON SHORES, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,382 in 130 payments from 16 companies in 2025. Trend: 2023 $649 · 2024 $2,705 · 2025 $2,382
Food & beverage: $2,382
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $482 |
| GENZYME CORPORATION | 17 | $421 |
| Incyte Corporation | 10 | $207 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 19 | $194 |
| UCB, Inc. | 10 | $184 |
| Janssen Biotech, Inc. | 10 | $166 |
| E.R. Squibb & Sons, L.L.C. | 10 | $135 |
| Arcutis Biotherapeutics, Inc. | 7 | $119 |
| Amgen Inc. | 6 | $111 |
| Galderma Laboratories, L.P. | 5 | $100 |
Products named: DUPIXENT, SKYRIZI, OPZELURA, Bimzelx, TREMFYA, Sotyktu, Zoryve, ILUMYA.
Industry payments across MI — which companies pay providers there.
